NO20042138L - Forbindelser og fremgangsmate for behandling av hyperaktiv blaere - Google Patents

Forbindelser og fremgangsmate for behandling av hyperaktiv blaere

Info

Publication number
NO20042138L
NO20042138L NO20042138A NO20042138A NO20042138L NO 20042138 L NO20042138 L NO 20042138L NO 20042138 A NO20042138 A NO 20042138A NO 20042138 A NO20042138 A NO 20042138A NO 20042138 L NO20042138 L NO 20042138L
Authority
NO
Norway
Prior art keywords
compounds
sup
methods
treatment
hyperactive bladder
Prior art date
Application number
NO20042138A
Other languages
English (en)
Norwegian (no)
Inventor
Russel Bialecki
Cathy Dantzman
Keith Herzog
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20042138L publication Critical patent/NO20042138L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
NO20042138A 2001-11-02 2004-05-25 Forbindelser og fremgangsmate for behandling av hyperaktiv blaere NO20042138L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103795A SE0103795D0 (sv) 2001-11-02 2001-11-02 Compounds and method for the treatment of överactive bladder
PCT/SE2002/001991 WO2003037889A1 (fr) 2001-11-02 2002-11-01 Composes et methode de traitement de la vessie hyperactive

Publications (1)

Publication Number Publication Date
NO20042138L true NO20042138L (no) 2004-05-25

Family

ID=20285984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042138A NO20042138L (no) 2001-11-02 2004-05-25 Forbindelser og fremgangsmate for behandling av hyperaktiv blaere

Country Status (16)

Country Link
US (1) US7368461B2 (fr)
EP (1) EP1444220B1 (fr)
JP (1) JP2005511571A (fr)
KR (1) KR20040053239A (fr)
CN (1) CN1610676A (fr)
AT (1) ATE353886T1 (fr)
BR (1) BR0213832A (fr)
CA (1) CA2465429A1 (fr)
DE (1) DE60218203T2 (fr)
ES (1) ES2282491T3 (fr)
IL (1) IL161600A0 (fr)
MX (1) MXPA04004075A (fr)
NO (1) NO20042138L (fr)
SE (1) SE0103795D0 (fr)
WO (1) WO2003037889A1 (fr)
ZA (1) ZA200403206B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
DE102004001873A1 (de) * 2004-01-14 2005-09-29 Bayer Healthcare Ag Cyanopyrimidinone
WO2006121389A1 (fr) * 2005-05-10 2006-11-16 Astrazeneca Ab Utilisation d'un antagoniste du recepteur de la neurokinine-2 pour traiter ou prevenir l'hyperactivite du detrusor
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基-雜環化合物
CN112915266B (zh) * 2021-02-05 2021-11-09 武汉磁济科技有限公司 一种人工膀胱铁磁复合体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9310713D0 (en) 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9322643D0 (en) * 1993-11-03 1993-12-22 Zeneca Ltd Lactam derivatives
US6008223A (en) 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
GB9505084D0 (en) 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
WO2000034234A1 (fr) * 1998-12-04 2000-06-15 Rimma Iliinichna Ashkinazi Aryl- et heteroarylamides d'acides carboalcoxysulfaniliques
GB9826941D0 (en) 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Also Published As

Publication number Publication date
SE0103795D0 (sv) 2001-11-02
DE60218203D1 (de) 2007-03-29
JP2005511571A (ja) 2005-04-28
ATE353886T1 (de) 2007-03-15
KR20040053239A (ko) 2004-06-23
DE60218203T2 (de) 2008-01-03
CA2465429A1 (fr) 2003-05-08
IL161600A0 (en) 2004-09-27
ES2282491T3 (es) 2007-10-16
WO2003037889A8 (fr) 2004-05-06
CN1610676A (zh) 2005-04-27
WO2003037889A1 (fr) 2003-05-08
EP1444220B1 (fr) 2007-02-14
BR0213832A (pt) 2004-08-31
MXPA04004075A (es) 2004-07-23
US7368461B2 (en) 2008-05-06
EP1444220A1 (fr) 2004-08-11
ZA200403206B (en) 2005-02-22
US20050203113A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
WO2006044362A3 (fr) Antagonistes du recepteur 1 de n-sulfonylpiperidine cannabinoide
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
DZ3186A1 (fr) Ptéridinones utilisées comme inhibiteurs de kinase.
DK0842934T3 (da) 5-HT1F agonister
SE9900100D0 (sv) New compounds
HK1068136A1 (en) Muscarinic antagonists
RS50814B (sr) Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
MY139124A (en) Gyrase inhibitors and uses thereof
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
BRPI0407841A (pt) inibidores heterocìclicos de quinase
SE0003476D0 (sv) Compounds
DE60325377D1 (de) Motilidverbindungen
MXPA02000330A (es) Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.
NO20042138L (no) Forbindelser og fremgangsmate for behandling av hyperaktiv blaere
WO2000040232A3 (fr) Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires
NO20002408D0 (no) 5-HT1F antagonister
GB0223223D0 (en) Organic compounds
MXPA04004071A (es) Metodo para tratamiento de vejiga hiperactiva.
WO2003010160A3 (fr) Composes chimiques
DE602004030536D1 (de) Pyrrolidinohydrochinazoline
CA2420999A1 (fr) Composes heterocycliques substitues en position 2